A global comparative analysis of guidelines for herbal medicines Pharmacopoeia and Good Manufacturing Practice, with a case study of Panax ginseng C.A Meyer-Reference-Cited by-同舟云学术

A global comparative analysis of guidelines for herbal medicines Pharmacopoeia and Good Manufacturing Practice, with a case study of Panax ginseng C.A Meyer

Published:2024-09 Issue: Volume:70 Page:102394
ISSN:1876-3820
Container-title:European Journal of Integrative Medicine
language:en
Short-container-title:European Journal of Integrative Medicine

Author:

Xu Minghui,Nguyen Dung Thuy,Purja Sujata,Kim Eunyoung^ORCID

Publisher

Elsevier BV

Reference65 articles.

1. World Health Organization (WHO), WHO establishes the Global Centre for Traditional Medicine in India. https://www.who.int/news/item/25-03-2022-who-establishes-the-global-centre-for-traditional-medicine-in-india, 2022 (accessed in 2023).

2. Traditional medicine in China, Korea, and Japan: a brief introduction and comparison;Park;Evid. Based Complement. Alternat. Med.,2012

3. Current status and future perspective of external herbal dispensaries preparing traditional herbal medicine in South Korea: the first National-Wide Survey results;Sung;BMC Complement. Med. Ther.,2020

4. Use of and attitudes towards herbal medicine during the COVID-19 pandemic: a cross-sectional study in Vietnam;Nguyen;Eur. J. Integr. Med.,2021

5. Revisiting traditional Chinese materia medica from European historical collections and perspective for current use;Jia;J. Tradit. Complement. Med.,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Traditional Chinese medication qili qiangxin capsule protects against myocardial ischemia-reperfusion injury through suppressing autophagy via the phosphoinositide 3-kinase/protein kinase B/forkhead box O3 axis;Journal of Ethnopharmacology;2025-01